English
Attend Our Free Virtual Workshop Translating Science into Patient Care: New Results on Early Sepsis Indicator Performance in Real-life Clinical Settings
Sepsis is a complex and severe syndrome associated with a dysregulated immune response against infection, affecting more than 30 million patients worldwide.1 Early detection of sepsis or infection, which may progress to sepsis, is extremely important as it can improve patient outcomes and save money. Our hematology technology with near-native state cellular analysis made it possible to bring a new sepsis biomarker, Early Sepsis Indicator (ESId), to the hematology platform. With this innovation today, the hematology laboratory plays a vital role in rapidly identifying septic patients or those who are at high risk of developing sepsis.
Speakers:
Julian Chen-June Seak, M.D., MSc.Department of Emergency Medicine, Lin-Kou Medical Center, Chang Gung Memorial,.
Taiwan School of Medicine, Chang Gung University.
Taiwan, Taiwan Society of Emergency Medicine.
Dr. Chen-June Seak is the deputy director and a senior consultant in the Department of Emergency Medicine, Lin-Kou Medical Center, Chang Gung Memorial Hospital and assistant professor at School of Medicine, Chang Gung University in Taiwan. He is a board-certified intensive care and toxicology specialist. Dr. Seak’s research interests include emergency department scoring systems and methods of early risk stratification. He has co-authored over 50 papers in various international peer-reviewed, indexed scientific journals and local journals to date, and is the associate editor of Journal of Acute Medicine (JACME). He is also the current Secretary-General of Taiwan Society of Emergency Medicine (TSEM).
Professor Chan-Jeoung Park, M.D., Ph.D.Department of Laboratory Medicine, ASAN Medical Center,
University of Ulsan College of Medicine
Seoul, Korea.
Chan-Jeoung Park is a professor in the Department of Laboratory Medicine at Asian Medical Center, University of Ulsan College of Medicine in Seoul, Korea. She received her M.D., M.S. and Ph.D. degrees from the College of Medicine and Post-graduate schools of Medicine at Seoul National University. Dr.Park completed her internship and residency in the Dept. of Laboratory Medicine, Seoul National University Hospital where she studied hematology, with emphasis in pathology at Pittsburgh University Hospital in the U.S. Dr. Park's diagnostic and research expertise are in hematologic malignancies with emphasis in leukemia in hematopathology and flow cytometry and the clinical utility of automatic hematology analyzers in laboratory hematology. She has published many papers as a first or corresponding author in the several international journals and has received academic awards from the Korean Federation of Science & Technology Societies, the Korean Society for Laboratory Medicine, the Korean Society for Laboratory Hematology and the Korean Society of Hematology. Dr.Park has served as president of the Korean Society for Laboratory Hematology and congress chairwoman of the Korean Society of Hematology. She is currently the president of the Korean Society for Laboratory Medicine.
